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During phagocytosis, microorganisms are taken up
by immune cells into phagosomes. Through mem-
brane-trafficking events mediated by SNARE pro-
teins, phagosomes fuse with lysosomes, generating
degradative phagolysosomes. Phagolysosomes
contribute to host immunity by linking microbial
killing within these organelles with antigen process-
ing for presentation on MHC class I or II molecules
to T cells. We show that the intracellular parasite
Leishmania evades immune recognition by inhibiting
phagolysosome biogenesis. The Leishmania cell
surface metalloprotease GP63 cleaves a subset of
SNAREs, including VAMP8. GP63-mediated VAMP8
inactivation or Vamp8 disruption prevents the
NADPHoxidase complex fromassembling onphago-
somes, thus altering their pHanddegradativeproper-
ties. Consequently, the presentation of exogenous
Leishmania antigens on MHC class I molecules,
also knownascross-presentation, is inhibited, result-
ing in reduced T cell activation. These findings indi-
cate that Leishmania subverts immune recognition
by altering phagosome function and highlight the
importance of VAMP8 in phagosome biogenesis
and antigen cross-presentation.
INTRODUCTION
Phagocytosis, the process by which cells of the immune system
such asmacrophages and dendritic cells engulf microorganisms
at sites of infection, leads to the formation of phagosomes,
where microbes are killed and processed for antigen presenta-
tion (Botelho and Grinstein, 2011; Boulais et al., 2010; Joffre
et al., 2012). Because phagosomes play a key role in both innateCand adaptive immunity, the functional properties of these organ-
elles and the molecular mechanisms regulating their interactions
with pathogens have been the attention of a large number of
studies in the last 25 years. These studies have highlighted the
diversity of molecular strategies used by a variety of microorgan-
isms to interfere with the maturation of phagosomes into phago-
lysosomes, a process referred to as phagolysosome biogenesis
(Alix et al., 2011; Flannagan et al., 2009). Phagolysosome
biogenesis is essential for the acquisition of the microbicidal
properties required for the killing of microbes (Desjardins et al.,
2005; Jutras and Desjardins, 2005). This process is driven by
complex sets of membrane-trafficking events involving soluble
N-ethylmaleimide-sensitive factor attachment receptor (SNARE)
protein-regulated sequential fusion events between phago-
somes and intracellular organelles, including early endosomes,
late endosomes, and lysosomes (Stow et al., 2006). These inter-
actions allow the coordinated transfer of sets of hydrolases, as
well as the acquisition of the oxidative machinery, involved in
the killing of microorganisms and the processing of some of their
proteins for antigen presentation on MHC class II molecules.
Furthermore, the interaction between phagosomes and subre-
gions of the endoplasmic reticulum plays a key role in the contri-
bution of this organelle to cross-presentation, the process by
which exogenous microbial antigens are presented on MHC
class I molecules (Campbell-Valois et al., 2012; Jutras and Des-
jardins, 2005).
The protozoan Leishmania parasitizes phagocytic cells and
causes a spectrum of human diseases known as leishmaniases.
Once inoculated by sand fly vectors into mammals, promasti-
gotes are taken up by macrophages. We previously reported
that one mechanism used by promastigotes to evade the micro-
bicidal consequences of phagocytosis is the inhibition of phag-
olysosome biogenesis (Desjardins and Descoteaux, 1997).
Hence, promastigotes are internalized in phagosomes that
poorly interact with late endosomes and lysosomes and display
a delayed recruitment of LAMP-1 (Dermine et al., 2000; Sciani-
manico et al., 1999; Spa¨th et al., 2003). Lipophosphoglycan
(LPG), the major promastigote surface glycolipid, is responsibleell Host & Microbe 14, 15–25, July 17, 2013 ª2013 Elsevier Inc. 15
Figure 1. Leishmania Promastigotes Target Host Cell SNAREs
(A) Confocal microscopy images of BMMs 2 hr after internalization of Zym,WT, orDlpg2 L. donovani promastigotes. VAMP3 and VAMP8 are in green; nuclei are in
blue. Asterisks show phagosomes containing Zym, and white arrowheads show phagosomes containing L. donovani. Red arrowheads show uninfected cells.
DIC, differential interference contrast.
(B) VAMP8 and actin in lysates of BMMs infected with L. donovani promastigotes for the indicated time points.
(C) VAMP8, VAMP3,GP63, and actin in lysates of BMMs infectedwith L. donovani amastigotes for the indicated time points. Controls consisted of BMMs infected
for 2 hr with L. donovani promastigotes or with latex beads. Similar results were obtained in three independent experiments. See also Figure S1.
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Descoteaux, 2008). LPG inserts itself in the phagosome mem-
brane where it destabilizes lipid microdomains (Dermine et al.,
2005), thereby impairing processes required for the generation
of amicrobicidal compartment within macrophages. One conse-
quence of LPG-mediated microdomain disorganization is the
exclusion of the membrane fusion regulator synaptotagmin V
(Syt V) from the phagosome early after infection. This in turn
abrogates recruitment of the V-ATPase and impedes phago-
some acidification (Vinet et al., 2009). Targeting of the phago-
some fusion machinery thus represents an efficient way for
Leishmania promastigotes to create an intracellular niche favor-
able to the establishment of infection.
These findings led us to seek further insight into the impact of
Leishmania promastigotes on the host cell fusion machinery that
controls phagosome maturation and function. Here, we provide
evidence that Leishmania promastigotes impair phagosome
maturation and antigen cross-presentation through the proteo-
lytic cleavage of SNAREs.
RESULTS
Leishmania Promastigotes Exclude SNAREs from
Phagosomes
Infection with the intracellular pathogen Leishmania is initiated
when promastigotes are engulfed by phagocytic cells at the
site of inoculation. The main survival strategy of this parasite is
then to inhibit phagolysosome biogenesis. An important aspect
of the molecular mechanisms enabling this inhibition relies on16 Cell Host & Microbe 14, 15–25, July 17, 2013 ª2013 Elsevier Inc.the exclusion of Syt V, a key regulator of membrane fusion,
from the phagosomal membrane (Vinet et al., 2009). In addition
to Syt V, the phagosome proteome contains several soluble
N-ethylmaleimide-sensitive factor attachment protein receptors
(SNAREs) (Boulais et al., 2010). Hence, it is conceivable that
multiple aspects of phagolysosome biogenesis, crucial for the
acquisition of the microbicidal properties of this organelle and
its ability to properly process proteins for antigen presentation,
are regulated by a series of membrane fusion regulators such
as SNAREs. To determine whether Leishmania impairs the
recruitment of other SNAREs, we infected bone marrow-derived
macrophages (BMMs) with L. donovani promastigotes and
assessed the intracellular localization of VAMP3 and VAMP8,
two SNAREs known to be present on phagosomes (Furuta
et al., 2010; Kay et al., 2006; Murray et al., 2005). Immunofluores-
cence analyses at the confocal microscope show that both
VAMP3 and VAMP8 were present on zymosan (Zym)-containing
phagosomes at 2 and 6 hr after the initiation of phagocytosis
(Figure 1A). In contrast, these two SNAREs were absent
from the majority of phagosomes containing wild-type (WT)
L. donovani promastigotes (Figure 1A). Because the virulence
glycolipid LPG is the only known Leishmania factor responsible
for phagosome remodeling (Dermine et al., 2001; Desjardins
and Descoteaux, 1997; Lodge et al., 2006; Scianimanico et al.,
1999; Vinet et al., 2009), we tested whether this molecule
was involved in the exclusion of VAMP3 and VAMP8 from
Leishmania-containing phagosomes. Our results show that
VAMP3 and VAMP8 are still excluded from phagosomes con-
taining the LPG-defective Dlpg2 L. donovani mutant, indicating
Figure 2. GP63 Mediates SNARE Cleavage
in Infected BMMs
(A) Kinetics of VAMP8 cleavage by L. major
and GP63 accumulation in lysates of BMMs was
assessed by immunoblot analysis.
(B) VAMP8 and VAMP3 in lysates from BMMs
infected for 2 hr with WT, Dgp63, or Dgp63+gp63
L. major promastigotes.
(C) GST-VAMP8 was incubated with L. major
promastigotes, and cleavage was assessed by
immunoblot analysis.
(D) Confocal microscopy images of BMMs
infected for 2 hr with WT, Dgp63, or Dgp63+gp63
L. major promastigotes. VAMP8 is in green; nuclei
are in blue. White arrowheads show phagosomes
containing L. major. Red arrowheads show unin-
fected cells.
(E) Quantification of VAMP8-positive phagosomes
at 2 and 6 hr after infection. Data are presented as
the mean ± SD of three independent experiments.
*p% 0.05; **p% 0.005. See also Figure S2.
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SNAREs (Figure 1A). This finding pointed toward the existence of
an unsuspected mechanism used by Leishmania promastigotes
to remodel their phagosomes. Intriguingly, we observed that
VAMP3 and VAMP8 were not only excluded from phagosomes
but that the intensity of the labeling for these proteins was also
reduced throughout the cell in BMMs infected with L. donovani
promastigotes compared to BMMs that had internalized Zym,
or to uninfected BMMs (Figure 1A). Western blotting analyses
confirmed that the amount of both proteins was much lower in
infected cells. Furthermore, the appearance of a second band
of lower molecular mass suggested that VAMP8 was actually
cleaved in infected cells (Figure 1B). Thus, the cleavage of key
proteins involved in membrane trafficking may be part of a
strategy used by Leishmania promastigotes to remodel their
intracellular niche.
GP63 Mediates the Cleavage of SNAREs
The cleavage of VAMP8 in Leishmania-infected BMMs is remi-
niscent of that of SNAREs catalyzed by the zinc-dependent
metalloproteases botulinum neurotoxins and antarease from
scorpion venom (Fletcher et al., 2010; Montal, 2010). We there-
fore investigated whether a Leishmania protease is involvedCell Host & Microbe 14, 1in VAMP8 cleavage. The Leishmania
genome encodes several proteases
(Ivens et al., 2005) including the surface
GPI-anchored GP63, a zinc-dependent
metalloprotease expressed at high levels
in promastigotes (Etges et al., 1986).
GP63 is a virulence factor that contrib-
utes to the pathogenesis of Leishmania
by cleaving molecules controlling a vari-
ety of host defense mechanisms (Con-
treras et al., 2010; Corradin et al., 1999;
Gomez et al., 2009; Halle´ et al., 2009; Jar-
amillo et al., 2011; Joshi et al., 2002). Dur-
ing the differentiation of promastigotesinto amastigotes, GP63 is downregulated (Figure S1 available
online). Interestingly, we did not observe cleavage of either
VAMP8 or VAMP3 in BMMs infected with L. donovani amasti-
gotes, and this corresponds to the absence of GP63 (Figure 1C).
These findings lent support to the possibility that GP63 was
responsible for the cleavage of VAMP8 and VAMP3 in BMMs
infected with promastigotes. The availability of a Dgp63 mutant
in L. major allowed us to directly test this hypothesis (Joshi
et al., 2002). We first showed that, similar to L. donovani, infec-
tion with L. major promastigotes resulted in a cleavage of
VAMP8 that was detectable as early as 30min postinfection (Fig-
ure 2A). Remarkably, VAMP8 remained intact in cells infected
with the Dgp63 mutant (Figure 2B). The ability to cleave
VAMP8 was regained when cells were infected with the add-
back mutant (Dgp63+gp63 L. major) promastigotes. VAMP3
was also degraded in a GP63-dependent manner (Figure 2B).
By incubating purified glutathione S-transferase (GST)-tagged
VAMP8 with L. major promastigotes, we showed that GP63
directly cleaves VAMP8 (Figure 2C). Collectively, these results
identify GP63 as the parasite molecule responsible for the cleav-
age of host SNAREs during infection (Figures 2 and S2). Using
confocal microscopy, we confirmed that phagosomal exclusion
of VAMP8 (Figures 2D and 2E) and VAMP3 (data not shown) is5–25, July 17, 2013 ª2013 Elsevier Inc. 17
Figure 3. Leishmania Promastigotes Inhibit Cross-Presentation in a GP63-Dependent Manner
(A) Representative FACS histograms of CD8 OT-I T cell CD69 expression after culture with BMMs or BMDCs infected with WT or Dgp63 L. major-OVA
promastigotes. % of Max., percentage of maximum.
(B) Cells infected with WT or Dgp63 L. major-OVA promastigotes or with nontransfected parasites were incubated with CD8 OT-I T cells, and cross-presentation
was assessed by CD69 expression. Right upper-panel shows VAMP8 and actin in noninfected BMDCs or infected with WT, Dgp63, Dgp63+gp63 L. major, or
L. tarentolae promastigotes. Ctl, control.
(C) VAMP8 in latex bead-containing phagosomes isolated from noninfected cells (Ctl) or infected with WT, Dgp63, or Dgp63+gp63 promastigotes.
(D) Cells were infected with WT, Dgp63, Dgp63+gp63 L. major, or L. tarentolae promastigotes or left untreated (Ctl). OVA-coated beads or SIINFEKL peptide
(assessment of surface MHC class I expression, upper graph) was added, and cross-presentation and MHC I expression were evaluated using the B3Z T cell
hybridoma.
(E) Immunoblot analysis of molecules involved in the MHC class I machinery (calnexin, Sec61, TAP1) and VAMP8 in noninfected cells (Ctl) or cells infected with
Dgp63 or Dgp63+gp63 L. major promastigotes.
(legend continued on next page)
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mechanism used by Leishmania parasites to control biogenesis
of the parasitophorous vacuole, whereby GP63 targets SNAREs
that regulate vesicular trafficking to and from phagosomes.
Leishmania Impairs Antigen Cross-Presentation
through the Action of GP63
In addition to the killing of the parasite, the processing of
Leishmania proteins for antigen presentation on both MHC
class II molecules and MHC class I molecules during cross-
presentation is a highly regulated process that requires molec-
ular properties acquired during phagolysosome biogenesis
(Jutras and Desjardins, 2005). Although the precise molecular
mechanisms involved in the processing of Leishmania proteins
for cross-presentation are still poorly understood, it is assumed
that parasite proteins are proteolytically cleaved in maturing
phagosomes, generating peptides that can either be directly
loaded on MHC class I molecules in phagosomes or translo-
cated to the cytoplasm for further processing by the proteasome
(Bertholet et al., 2005, 2006). Hence, trafficking events involved
in phagolysosome biogenesis are likely to play key roles in
cross-presentation during Leishmania infection. In that context,
we elected to study whether the GP63-dependent cleavage of
SNAREs observed during infection alters key immune processes
such as cross-presentation in BMMs andBMDCs (bonemarrow-
derived dendritic cells).
To test this hypothesis in the context of Leishmania infection,
we produced WT L. major and Dgp63 L. major expressing oval-
bumin (OVA) (L. major-OVA) to measure the cross-presentation
of the OVA antigen on MHC class I molecules. BMMs and
BMDCs were infected with promastigotes before the addition
of OVA-specific CD8+ OT-I T cells, and cross-presentation was
assessed through the expression of the early T cell activation
marker CD69. Negative controls consisted of L. major promasti-
gotes not expressing OVA. Our results showed that cross-pre-
sentation was significantly higher in BMMs and BMDCs infected
with Dgp63 L. major-OVA promastigotes compared to cells
infected with WT parasites (Figures 3A and 3B), demonstrating
that GP63 endows these parasites with the ability to alter
cross-presentation. A key question that arose at this point was
whether the action of GP63 was restricted to phagosomes con-
taining parasites or if the whole cellular machinery of cross-pre-
sentation was altered. We addressed this issue by showing that
VAMP8 present on latex bead-containing phagosomes formed
in cells infected with WT and Dgp63+gp63 L. major promasti-
gotes was also cleaved (Figure 3C). This result allowed us to
test whether the cleavage of VAMP8 by GP63 is sufficient to alter
cross-presentation by measuring the presentation of the
SIINFEKL peptide following the internalization of OVA-coated
latex beads in infected cells. Indeed, cross-presentation from
OVA-coated beads was greatly diminished in BMMs and
BMDCs infected with WT promastigotes compared to unin-
fected cells or cells infected with the Dgp63 mutant (Figure 3D).
Infection with the GP63 add-back parasites (Dgp63 + gp63)(F) BMDCs were infected with WT L. donovani promastigotes (promast.) or amast
(assessment of surface MHC class I expression, upper graph) was then added
hybridoma. Data are presented as the mean ± SEM of one experiment represent
Figure S3.
Crestored the ability of the Dgp63 mutant to inhibit cross-presen-
tation, highlighting the global effect of GP63 on this immune pro-
cess. Interestingly, the nonpathogenic parasite L. tarentolae, in
which GP63 is inactive (Campbell et al., 1992), was unable to
cleave VAMP8 and to inhibit cross-presentation (Figures 3B
and 3D). The inhibition of cross-presentation by L. major
promastigotes was not caused by a decreased MHC class I
expression, as shown by the SIINFEKL peptide-loading control
experiment (Figure 3D), or by a defect in phagocytosis (Fig-
ure S3). Furthermore, infection with Leishmania promastigotes
had no noticeable effect on the phagosomal recruitment of mol-
ecules involved in the antigenic peptide loading on MHC class I
(Figure 3E). Importantly, amastigotes, in which GP63 is down
modulated (Figure 1C), did not inhibit cross-presentation (Fig-
ure 3F). Collectively, these results show that a microbial mol-
ecule, GP63, directly impairs the ability of infected cells to
cross-present exogenous peptides on MHC class I molecules.
These results also support the hypothesis that Leishmania pro-
mastigotes transiently alter antigen cross-presentation by the
degradation of a restricted set of molecules including SNAREs.
Thus far, our study also indicates that the well-established latex
bead system can be used to decipher the molecular mecha-
nisms enabling GP63 to cleave VAMPs and the potential role
played by these proteins in the regulation of cross-presentation.
VAMP8 Is Required for Antigen Cross-Presentation
Thus far, our results suggest that the cleavage of SNAREs by
GP63 might be responsible for the alteration of cross-presenta-
tion in Leishmania-infected cells. Whereas VAMP3 regulates
cytokine secretion at the phagocytic cup (Murray et al., 2005), lit-
tle is known about the role of VAMP8 in phagosome function.
However, VAMP8 is present on late endosomeswhere it controls
homotypic fusion between these organelles (Pryor et al., 2004).
Considering the importance of the regulation of fusion events
during phagolysosome biogenesis, including phagosome-late
endosome fusion (Desjardins et al., 1997), we investigated
whether VAMP8 is required for cross-presentation. To this end,
we used BMMs and BMDCs from VAMP8 null mice (Wang
et al., 2004). Using our OVA-coated bead assay, we observed
a decrease of around 50% in the level of cross-presentation in
Vamp8/BMDCs and BMMs compared toWT cells (Figure 4A).
This inhibition was not the consequence of a reduced MHC
class I expression (Figure 4A, inset) or due to a defect in phago-
cytosis (Figure S4A) in Vamp8/ cells. In addition, the absence
of VAMP8 did not significantly affect the recruitment of the
machinery involved in the antigenic peptide loading on MHC
class I to phagosomes (Figure S4B). To determine whether the
effect of GP63-mediated cleavage of VAMP8 on cross-presenta-
tion was specific, we assessed the impact of GP63 and VAMP8
onMHC class II-restricted antigen presentation in BMDCs. Inter-
estingly, we found that this process was also inhibited by GP63
(Figure S4C). However, in contrast to cross-presentation, MHC
class II-restricted antigen presentation was normal or even
slightly superior in the absence of VAMP8 (Figure S4D). Theseigotes (amast.), or left untreated (Ctl). OVA-coated beads or SIINFEKL peptide
. Cross-presentation and MHC I expression were evaluated using B3Z T cell
ative of at least two independent experiments. *p% 0.05; **p% 0.01. See also
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Figure 4. VAMP8 Regulates Antigen
Cross-Presentation through the Control
of Phagosome Acidification and Antigen
Degradation
(A) Vamp8+/+ and Vamp8/ BMMs or BMDCs
were fed with OVA-coated beads or SIINFEKL
peptide (upper graph). Cross-presentation and
MHC I expression were evaluated using B3Z T cell
hybridoma.
(B) Vamp8+/+and Vamp8/ BMDCs (left panel)
and Vamp8+/+ BMDCs infected with WT or Dgp63
L. major promastigotes (right panel) were fed with
FITC-coated beads to evaluate phagosomal pH.
(C) Vamp8+/+ and Vamp8/ BMDCs (left panel)
and Vamp8+/+ BMDCs infected with WT or Dgp63
promastigotes (right panel) were fed with OVA-
DQ-coated beads to assess phagosomal prote-
olysis. Data are presented as the mean ± SEM of
one experiment representative of at least three
independent experiments. *p% 0.05; **p% 0.01.
See also Figure S4.
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the key molecules targeted by Leishmania to specifically alter
cross-presentation.
Our data indicate that the role of VAMP8 in cross-presentation
within phagosomes can be tested either in uninfected Vamp8/
BMDCs and BMMs or/and in Leishmania-infected WT BMDCs
and BMMs. Accordingly, we hypothesized that the phagosome
functional properties observed in Vamp8/ cells should be
similar to those observed in Vamp8+/+ cells infected with WT
L. major promastigotes (a condition that degrades VAMP8).
Based on this assumption, we first compared phagosomal acid-
ification (a hallmark of phagosome maturation). As shown in Fig-
ure 4B, the phagosomal pH was significantly lower in Vamp8/
BMDCs at all time points evaluated after phagocytosis
compared to Vamp8+/+ BMDCs. Similarly, the phagosomal pH
was significantly lower in WT L. major-infected Vamp8+/+
BMDCs compared to uninfected BMDCs or to BMDCs infected
with the Dgp63 L. major mutant (Figure 4B). From these results,
we concluded that the presence of VAMP8 is required to main-
tain a near-neutral pH in BMDC phagosomes.
The pH in the phagosome lumen influences directly the pro-
teolytic activity and antigen processing within this organelle
(Delamarre et al., 2005). We therefore determined whether
the observed decrease in antigen cross-presentation in
Leishmania-infected WT BMDCs and in Vamp8/ BMDCs was
accompanied by a defect in phagosomal proteolytic activity.
Degradation of the general protease substrate DQ OVA was20 Cell Host & Microbe 14, 15–25, July 17, 2013 ª2013 Elsevier Inc.significantly increased in Vamp8/
BMDCs as well as in Vamp8+/+ BMDCs
infected with WT L. major, when
compared to uninfected and to Dgp63
L. major-infected Vamp8+/+ BMDCs (Fig-
ure 4C). The processing of antigens for
cross-presentation in phagosomes is
also tightly controlled by the oxidation
level generated through the NADPH oxi-
dase activity. Conflicting reports eitherlink the control of the proteolytic activity to a direct effect of
the NADPH oxidase on the phagosome pH level (Savina et al.,
2006) or through the redox modulation of local cysteine cathep-
sins (Rybicka et al., 2012). Remarkably, treatment with the
NADPH oxidase complex inhibitor diphenylene iodonium (DPI)
reversed the phagosomal proteolytic activity in Vamp8+/+
BMDCs to the levels observed in Vamp8/ BMDCs (Figure 4C).
Treatment of Dgp63 L. major-infected cells with DPI also led to
the levels of phagosomal proteolytic activity observed in WT
L. major-infected cells. These observations suggest that phago-
somal oxidative activity is impaired in Vamp8/ BMDCs and in
WT L. major-infected cells, which may be responsible for the
increased antigen degradation in those cells.
VAMP8 Regulates Phagosomal Oxidative Activity
To verify the possible involvement of VAMP8 in the regulation of
phagosomal oxidative activity, BMDCs that internalized dihydro-
rhodamine (DHR)-coated beads were analyzed by FACS for
ROS production. The phagosomal oxidative activity observed
in Vamp8+/+ BMDCs was inhibited by DPI, indicating that it
was predominantly generated by the NADPH oxidase complex.
In contrast, phagosomal oxidative activity was defective in
Vamp8/ BMDCs and was not further reduced by DPI (Fig-
ure 5A). Similar to Vamp8/ BMDCs, phagosomal oxidative
activity was impaired in Vamp8+/+ BMDCs infected with WT
L.majorpromastigotes in aGP63-dependentmanner (Figure 5A).
We concluded that VAMP8 is required for phagosomal oxidative
Figure 5. gp91phox Is Inefficiently Recruited
to the Phagosome in Vamp8–/– Cells
(A) Vamp8+/+ and Vamp8/ cells (left panel) or
Vamp8+/+ cells infected withWT orDgp63 L. major
promastigotes (right panel) were fed with DHR-
coated beads and assayed for phagosome
oxidation.
(B) gp91phox (green) and VAMP8 (red) partly co-
localize in BMDCs.
(C) Cells were fed with fluorescent latex beads
(red), and gp91phox (green) recruitment to the
phagosome was evaluated after 45 min. The lower
histogram shows the quantification of gp91phox
recruitment to phagosomes.
(D) The presence of NADPH oxidase subunits in
purified latex bead phagosome extracts (45 and
90 min) was assessed by immunoblots. The lower
histogram shows the densitometry quantification
of the gp91phox immunoblots.
(E) BMDCs expressing shRNA-targeting gp91phox
(gp91phox knockdown), nontargeting scramble
(Scr), control, or Vamp8/ BMDCs (left histo-
gram) and gp91phox knockdown or Scr BMDCs
infected or not with WT or Dgp63 promastigotes
(right histogram) were fed with OVA-coated beads
in the presence or not of DPI. Cross-presentation
or SIINFEKL peptide (assessment of surface MHC
class I expression, upper graph) was evaluated
using B3Z T cell hybridoma. Data are presented as
the mean ± SEM of one experiment representative
of at least two independent experiments. *p %
0.05; **p% 0.01. See also Figure S5.
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the alteration of oxidative activity in WT L. major-infected
BMDCs.
To further understand the mechanisms possibly linking
VAMP8 to the phagosomal oxidative activity, we assessed
whether this SNARE participates in the recruitment of the
NADPH oxidase complex subunits to phagosomes. A key
component of this complex, gp91phox, is found in late endo-
somes called ‘‘inhibitory lysosome-related organelles’’ in refer-
ence to the ability of these organelles to regulate phagosomal
proteolytic activity after NADPH complex recruitment (Savina
et al., 2006). VAMP8 also localizes to late endosomes (Pryor
et al., 2004). Immunofluorescence analyses indicate that
VAMP8 and gp91phox indeed partially colocalize in BMDCs (Fig-
ure 5B) and that in the absence of VAMP8, the recruitment ofCell Host & Microbe 14, 1gp91phox to phagosomes was strongly
inhibited (Figure 5C). To analyze further
the impact of VAMP8 on the recruitment
of components of the NADPH oxidase
to phagosomes, we purified phagosomes
from BMDCs at different time points after
the initiation of phagocytosis. Consistent
with the results obtained by confocal
microscopy (Figure 5C), we observed
an inhibition of gp91phox recruitment in
Vamp8/ phagosome extracts, whereas
recruitment of the other subunits was not
altered (Figure 5D). These results indicatethat VAMP8 is required for the recruitment of gp91phox to phag-
osomes, a process that plays a key role in the regulation of anti-
gen processing for cross-presentation. In agreement with these
observations, DPI inhibited cross-presentation in Vamp8+/+
BMDCs as well as in cells infected with Dgp63 L. major promas-
tigotes (Figure 5E). In contrast, DPI treatment did not further
inhibit cross-presentation in either Vamp8/ or gp91phox knock-
down BMDCs and WT L. major-infected Vamp8+/+ BMDCs (Fig-
ure 5E), consistent with the fact that phagosome oxidation is
already impaired in these cells (Figure 5A). To test whether our
results obtained with OVA-coated beads were also relevant in
Leishmania phagosomes, we infected BMDCs with WT or
Dgp63 L. major-OVA promastigotes and measured OT-I T cell
activation. Figures S5A and S5B show that DPI inhibited cross-
presentation of Leishmania-derived OVA in BMDCs infected5–25, July 17, 2013 ª2013 Elsevier Inc. 21
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tion was observed in WT L. major-OVA promastigote-infected
cells. Furthermore, compared to normal BMDCs, Vamp8/
BMDCs infected with Dgp63 L. major-OVA promastigotes dis-
played a strong defect for the activation of OT-I T cells, and no
further inhibition of cross-presentation was observed when we
added DPI (Figures S5C and S5D). Collectively, our results indi-
cate that cleavage of VAMP8 enables Leishmania promastigotes
to inhibit cross-presentation by impairing the recruitment of
gp91phox to phagosomes, a key step for the control of phagoso-
mal proteolysis. Consistently, the absence of VAMP8 resulted in
an increased susceptibility to L.major infection in amousemodel
of cutaneous leishmaniasis (Figure S5F).
DISCUSSION
In the present study, we unraveled a strategy used by
Leishmania parasites to evade immune recognition by inhibiting
cross-presentation, a process involved in the development of a
protective immune response during leishmaniasis (Belkaid
et al., 2002; Bertholet et al., 2006; Da-Cruz et al., 1994; Mu¨ller
et al., 1991; Sta¨ger and Rafati, 2012; Uzonna et al., 2004). We
found that cross-presentation is inhibited by GP63 and is
inhibited in the absence of VAMP8, supporting the proposal
that cleavage of this SNARE enables Leishmania promastigotes
to inhibit this important immune process. A recent publication
showed that Sec22b, a SNARE associated with the endoplasmic
reticulum and localized to the phagosome membrane, is also
required for cross-presentation (Cebrian et al., 2011). Accord-
ingly, it appears that the molecular mechanisms involved in
cross-presentation are finely regulated by series of SNAREs
that can be directly targeted by intracellular pathogens to
evade immune recognition. The findings that bacteria such as
Chlamydia and Legionella encode proteins displaying SNARE-
like motifs that interfere with the function of endocytic SNAREs
(Paumet et al., 2009; Wesolowski and Paumet, 2010) highlight
the significance of targeting these types of molecules to manip-
ulate the host response.
The processing of exogenous antigens for cross-presentation
within phagosomes is a highly complex process that requires
limited proteolytic activities regulated in part by the intraphago-
somal pH and the levels of hydrolytic enzymes (Delamarre et al.,
2005) (Trombetta et al., 2003). Recent reports indicated that
phagosomal proteolysis, and potentially pH, is regulated by the
activity of the NADPH oxidase complex (Savina et al., 2006;
Rybicka et al., 2012). In the absence of VAMP8, the pH within
the phagosome lumen was decreased, whereas the proteolytic
activity was increased. Furthermore, we observed a severe
impairment of the oxidative activity, together with an inhibition
of the recruitment of gp91phox to phagosomes, supporting the
link between oxidation and the regulation of proteolytic activities.
Interestingly, our results indicate that VAMP8 is required for the
early recruitment of gp91phox to phagosomes, which is crucial for
the establishment of the conditions required for the processing
of exogenous antigens for cross-presentation. Recent findings
indicated that SNAP-23 regulates the recruitment of gp91phox
to phagosomes (Sakurai et al., 2012). Because VAMP8 and
SNAP-23 can form SNARE complexes (Wang et al., 2004), it is
possible that both act in concert to control the association of22 Cell Host & Microbe 14, 15–25, July 17, 2013 ª2013 Elsevier Inc.gp91phox to phagosomes. Remarkably, the impairment of the
phagosomal properties in cells lacking VAMP8 also occurred
in a GP63-dependent way in Vamp8+/+ cells infected with
Leishmania promastigotes, supporting the concept that the
cleavage of this SNARE is a key aspect of the strategy used by
the parasite to subvert the immune response. In support to this
proposal, we found that the absence of VAMP8 resulted in an
increased susceptibility to L. major infection in a mouse model
of cutaneous leishmaniasis (Figure S5F). Future studies will be
aimed at elucidating the impact of VAMP8 on the immune
response during in vivo infection. Although VAMP8 clearly
plays a role in cross-presentation, other molecules targeted by
Leishmania may also be involved in this process. Hence, we
observed that cross-presentation is further decreased when
Vamp8/BMDCs are infected with L. major promastigotes (Fig-
ure S5E). Whether this is related to the cleavage of SNAP-23 or
syntaxin-4 (Figure S2) remains to be investigated.
We discovered that an intracellular pathogen can directly
target and cleave components of the membrane fusion machin-
ery of its host cells to inhibit antigen presentation. These findings
thus significantly contribute to our understanding of the mecha-
nisms associated with immune evasion during Leishmania infec-
tion. Our data clearly identified the metalloprotease GP63 as the
parasite molecule responsible for the cleavage of VAMP8. Our
observations that GP63-mediated cleavage of VAMP8 (and
other SNAREs) and the consequential inhibition of cross-presen-
tation are specific to the promastigote stage indicate that these
events are limited to the early phase of the establishment of
Leishmania infection. Sustained cleavage of SNAREs in parasit-
ized cells would most likely be deleterious for host cells and for
the parasites because the membrane fusion machinery must
remain operational to allow for the maintenance of amastigote-
harboring phagosomes and parasite replication. Themechanism
by which GP63 accesses and degrades host cell substrates
remains to be elucidated. The recent discovery that GP63 is a
constituent of exosomes released by Leishmania provides a
potential mechanism for the export of this molecule across the
phagosome membrane (Silverman et al., 2010). Furthermore,
previous studies indicated that GP63 is released from the para-
site surface, exits the phagosome, and colocalizes with lipid
microdomains on some of the macrophage membranes (Gomez
et al., 2009). Remarkably, the finding that sets of SNAREs
associate to various degrees with lipid microdomains (Gil et al.,
2005) may facilitate their encounter with GP63. Further studies
will address the relative contribution of other SNAREs in the
fine regulation of the membrane-trafficking events regulating
both the innate and adaptive immune response in antigen-
presenting cells.EXPERIMENTAL PROCEDURES
Animals and Cells
BALB/c, 129/SvJ, VAMP8 null (Wang et al., 2004), and Rag/ OT-I T cell
receptor transgenic mice (specific for the Kb-restricted OVA257-264 epitope)
were maintained in our animal facility. Animals were handled in strict accor-
dance with good animal practice as defined by the Canadian Council on
Animal Care, and animal work was approved by the Comite´ Institutionnel de
Protection des Animaux of INRS-Institut Armand-Frappier (protocol
0811-09). BMMs or BMDCs were obtained by growing bone marrow cells
from female mice for 7 days in Dulbecco’s modified Eagle’s medium with
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mented with 10% heat-inactivated FBS (Hyclone, Logan), 10 mM HEPES
(pH 7.4), and antibiotics (complete medium) in the presence of 15% (v/v)
L929 cell-conditioned medium as a source of CSF-1 for BMMs, or in the pres-
ence of 20 ng/ml GM-CSF for BMDCs. Cells were made quiescent by culturing
them in the absence of CSF-1 or GM-CSF for 18 hr prior to use. RAW 264.7
mouse macrophages were cultured in complete medium in a 37C incubator
with 5%CO2. The b-galactosidase-inducible OVA-specific CD8
+ T cell hybrid-
oma B3Z (provided by W. Heath, University of Melbourne) was maintained in
RPMI-1640medium supplemented with 5% (v/v) FCS, glutamine (2mM), peni-
cillin (100 U/ml), streptomycin (100 mg/ml), G418 (0.5 mg/ml), and hygromycin
B (100 mg/ml). The OVA323-339-specific, I-A
b-restricted BO97.10 hybridoma
(a kind gift from P. Marrack) was maintained in Kappler Marrack complete
tumor medium.
Parasites
Leishmania promastigotes (WT and Dlpg2 L. donovani LV9; WT, Dgp63, and
Dgp63+gp63 L. major Seidman clone A2; L. tarentolae) were grown at 26C
inM199medium supplementedwith 20%heat-inactivated FBS, 100 mMhypo-
xanthine, 40 mM HEPES, 5 mM hemin, 3 mM biopterin, 1 mM biotin, and antibi-
otics (Leishmaniamedium). L. donovani amastigotes were recovered from the
spleen of hamsters infected for 6–8 weeks. L. major promastigotes expressing
a secreted form of OVA (L. major-OVA) were generated by electroporating the
pKS-NEO SP:OVA construct, which encodes a fusion protein containing the
signal peptide of the L. donovani 30 nucleotidase-nuclease fused to a portion
of OVA protein (139–386) containing both MHC class I OVA257-264- and
class II OVA323-339-restricted epitopes (Bertholet et al., 2005) (kindly provided
by Alain Debrabant, FDA). Transfected parasites were grown in Leishmania
medium supplemented with 50 mg/ml G418. For infections, promastigotes
were used in the late stationary phase of growth (Vinet et al., 2009).
Reagents and Antibodies
Rabbit antibodies to VAMP8 and SNAP-23 were from Synaptic Systems. Rab-
bit antibodies to Syntaxin 3, VAMP3, Calnexin, and ERp57, and the mouse
monoclonal to Syntaxin 4 were from Abcam. Mouse monoclonal to b-actin
and rabbit anti-OVA were from Sigma-Aldrich. Mouse monoclonal antibodies
to GP63 were kindly provided by W. Robert McMaster (University of British
Columbia). Goat antibodies to TAP1 were from Santa Cruz Biotechnology.
Rabbit antibodies to Sec61 were from Affinity BioReagents. Mouse mono-
clonal antibody to NSF was a kind gift from Sidney Whiteheart (University of
Kentucky). Mouse monoclonal antibodies to gp91phox, CD8a APC-H7, Va2
PerCP, CD3 (conjugated to PE-Cy7), and CD69 (conjugated to APC) were
from BD Biosciences. Purified OVA (grade VI, 99% pure), DPI, CPRG (chloro-
phenol red-b-D-galactopyranoside), and PMA (phorbol myristate acetate)
were from Sigma-Aldrich. The SIINFEKL peptide was from AnaSpec.
Phagocytosis Assays
Complement opsonization of Leishmania promastigotes with BALB/c mouse
serum was done as described by Vinet et al. (2009). Cells were incubated
with Zym or parasites at a particle-to-cell ratio of 15:1 for different time points.
For FACS experiments, cells were incubated 30 min with 1.9 mm fluorescent
latex beads, previously coated with OVA. Cells were then washed in PBS,
5 mM EDTA to eliminate noninternalized beads. Cells were then cultured in
complete medium for various times of chase and then labeled with an anti-
OVA antibody. Phagocytosis was evaluated using FACSCalibur flow cytome-
ter, and noninternalized beads (OVA-positive cells) were excluded.
Microscopy and Immunofluorescence
Cells were fixed and permeabilized as described by Vinet et al. (2009). Phag-
osomal recruitment of VAMP8, VAMP3, and gp91phox was quantified by
immunofluorescence microscopy using an oil immersion Axio Observer Z1
microscope equipped with a Zeiss LSM780 confocal system. Results are
based on at least 300 cells in each independent experiment (100 cells per
each coverslip), and each experiment was repeated twice. For gp91phox
staining, cells were visualized with a wide-field microscope (DeltaVision
Elite Inverted Microscope) equipped with a CoolSNAP HQ2 camera using a
603/1.42 NA oil objective. Images were acquired and deconvoluted using
SoftWoRx Software (Applied Precision).CPhagosome Preparation
Cells were incubated for 15 min with 3.19 mm polystyrene magnetic particles,
then chased for different periods of time and disrupted in homogeneization
buffer. Magnetic phagosomes were removed from the postnuclear superna-
tant using a magnet, washed three times in cold PBS, and lysed. After
10 min at 4C, magnetic bead phagosomes were removed by centrifugation.
Phagosomes were also prepared using latex beads (Estapor) and discontin-
uous sucrose gradients as previously described by Desjardins et al. (1994).
Western Blot Analyses
Phagosomal and total cell lysate proteins were separated on 12% and 15%
SDS-PAGE, transferred onto Hybond-ECL membranes (Amersham Biosci-
ences), and immunodetection was achieved by chemiluminescence (Amer-
sham Biosciences).
In Vitro Cleavage Assay
Reactions were performed in 200 ml binding buffer (PBS 13, ZnCl2 1 mM) with
1 mg of purified protein. GST-tagged VAMP8 was incubated with 30 3 106
L. major promastigotes for various time points at room temperature (Gomez
et al., 2009) and subjected to western blot analyses.
Design of shRNA and Knockdown Strategy
Specific shRNAs targeting the gp91phox and nontargeting scramble control
were designed based on the sequences presented on the Sigma-Aldrich
MISSION-RNA website. Annealed forward and reverse hairpin oligonucleo-
tides were cloned into a modified pLKO.1-TRC1.5 vector where the puromy-
cin-resistance gene was replaced with mAmetrine. Lentiviral particles were
made by cotransfecting in HEK293T cells the shRNA-containing pLKO-mAM
vector along with pMD2-VSVG, pMDLg/pREE, and pRSV-REV. Viral superna-
tants were used to transduce BMDCs (day 2 of differentiation), and 4 days after
lentivirus transduction, cells were sorted according to mAmetrine fluores-
cence. Validation of the knockdown was done by real-time qPCR and western
blot analyses.
Antigen Presentation Assay
BMMs or BMDCs were infected for 6 hr with WT or Dgp63 L. major-OVA pro-
mastigotes, or with nontransfected promastigotes. Cells were then washed
and fixed for 5 min at 23Cwith 1% (w/v) paraformaldehyde, followed by three
washes in complete medium containing 0.1 M glycin. Purified OT-I T cells
(using EasySepMouse CD8+ T Cell Enrichment Kit; STEMCELL Technologies)
were then added for 16 hr, and T cell activation was assayed by assessing
CD69 expression within the CD3+CD8a+Va2+ population. Activation was
measured with a LSRFortessa flow cytometer.
For OVA latex bead assays, at 2 or 6 hr postinfection, 105 BMMs or BMDCs
were incubated with uncoated or OVA-coated 0.8 mm latex beads for 1 hr of
pulse, in the presence or not of DPI. Cells were incubated for a 3 hr chase, fixed
with 1% (w/v) paraformaldehyde, and washed in complete medium containing
0.1M glycin. For MHC class I and class II expression control, cells received the
SIINFEKL peptide or the OVA323-339 peptide, respectively, 30 min before the
end of the chase. Cells were then cultured for 12 hr at 37C together with
105 B3Z or BO97.10 cells for analysis of T cell activation. B3Z cells, which
express b-galactosidase upon specific recognition of the OVA257-264
(SIINFEKL)-H-2Kb complex, were washed in PBS and lysed (0.125 M Tris
base, 0.01 M cyclohexane diaminotetraacetic acid, 50% [v/v] glycerol,
0.025% [v/v] Triton X-100, and 3 mM dithiothreitol [pH 7.8]). A b-galactosidase
substrate buffer (1 mM MgSO4 3 7 H2O, 10 mM KCl, 0.39 M NaH2PO4 xH2O,
0.6 M Na2HPO4 3 7 H2O, 100 mM 2-mercaptoethanol, and 0.15 mM CPRG
[pH 7.8]) was added for 2–4 hr at 37C. Cleavage of CPRG was quantified in
a spectrophotometer as absorbance at 570 nm, reflecting T cell activation after
cross-presentation. Production of IL-2 by BO97.10 was measured by ELISA
(BioLegend).
Measurement of Phagosomal pH and Oxidation
Phagosome pH and oxidation were measured as described by Savina et al.
(2006). Polybead amino microspheres (3 mm; Polysciences) were covalently
coupled with FITC (Sigma-Aldrich) for measuring pH, or with DHR (Invitrogen)
for the measuring oxidation. In both cases, beads were also coupled to
FluoProbes 647 (pH insensitive and oxidation insensitive; Interchim). Cellsell Host & Microbe 14, 15–25, July 17, 2013 ª2013 Elsevier Inc. 23
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indicated times before FACS analyses, using a gating FCS/SSC selective for
cells that have phagocytosed one latex bead. For oxidation experiments,
PMA (1 mg/ml) was added after phagocytosis. For DPI assays, cells were incu-
bated in the presence of 10 mM DPI for 30 min before and during the 20 min
pulse. The ratio of the mean fluorescence intensity (MFI) emission between
the two dyes was determined. For pH measurement, values were compared
with a standard curve obtained by resuspending the cells that had phagocy-
tosed beads at a fixed pH (ranging from pH 4 to pH 8).
Measurement of OVA Phagosomal Degradation
Cells were incubatedwith 3 mmpolybeads coupled to DQOVA and FluoProbes
647 (Molecular Probes) for 20 min at 37C and washed three times with PBS.
At the indicated time points, OVA degradation was evaluated by flow cytom-
etry with the fluorescein MFI measure normalized by the FluoProbes
647 MFI values. For DPI assay, cells were incubated in the presence of
10 mM DPI for 30 min before and during the 20 min pulse.
In Vivo Leishmania Infections
Mice were infected by injecting L. major stationary-phase parasites (53 106 in
50 ml) into the right hind footpad of 6- to 8-week-old animals. Footpad swelling
was measured weekly for up to 10 weeks after infection using an electronic
caliper as described by Gomez et al. (2009).
Statistical Analysis
An unpaired t test was performed using GraphPad software to assess whether
the differences between control and infected groups were significant or not.
p values <0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
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